HKEX Filings
-
May 26, 2026
(1) Proposed grant of general mandates to repurchase shares and to issue new shares and/or sell or transfer treasury shares; (2) Proposed re-election of the retiring directors; (3) Proposed re-appointment of auditor; (4) Proposed amendments to the memorandum and articles of association; and (5) Notice of annual general meeting
-
May 26, 2026Notice of Annual General Meeting
-
May 26, 2026Form of Proxy for Use at Annual General Meeting
-
May 6, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2026
-
Apr 23, 20262025 Annual Report
-
Apr 23, 2026Letter to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
-
Apr 23, 2026Letter to Non-Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications and Reply Form
-
Apr 9, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2026
-
Apr 2, 2026Inside Information - Supplemental Announcement in Relation to Inside Information
-
Mar 30, 2026Voluntary Announcement Clover Completes Enrollment in Australian Phase 2 Clinical Trial for RSV + hMPV + PIV3 Respiratory Combination Vaccine Candidates
-
Mar 27, 2026Grant of Options Pursuant to the Post-IPO Share Option Plan and Grant oOf RSUs Pursuant to the RSU Scheme
-
Mar 26, 2026Annual Results Announcement for The Year Ended December 31, 2025 and Proposed Amendments to the Memorandum and Articles of Association
-
Mar 25, 2026Voluntary Announcement Clover Announces Additional Positive US Phase I Clinical Data for RSV Re-Vaccination in Older Adults
-
Mar 22, 2026Inside Information - Settlement Announcement with GAVI
-
Mar 13, 2026Date of Board Meeting
-
Mar 5, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2026
-
Feb 4, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2026
-
Jan 12, 2026Voluntary Announcement Clover Initiates Phase 2 Clinical Trial for RSV-hMPV-PIV3 Respiratory Combination Vaccine Candidates
-
Jan 7, 2026Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2025
-
Dec 4, 2025Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2025
